Pilot program implements real-time reporting of endpoints in clinical trials, enhancing data transparency.
The FDA has launched a pilot program to establish real-time clinical trials that includes two proof-of-concept clinical trials that will report endpoints and data signals in real time. AstraZeneca is conducting TrAVeRse, a phase II trial in treatment-naïve mantle cell lymphoma, and Amgen is planning the phase Ib STREAM-SCLC study in limited-stage small cell lung carcinoma.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: